| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/17/2003 | US20030073813 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073810 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/17/2003 | US20030073809 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/17/2003 | US20030073659 Encapsulation of virus; genetic engineering; packaging signal |
| 04/17/2003 | US20030073654 Stabilized transient gene expression |
| 04/17/2003 | US20030073653 Method for transferring nucleic acid into striated muscles |
| 04/17/2003 | US20030073652 Ex-vivo and in vivo factor XII gene therapy for hemophilia A and B |
| 04/17/2003 | US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering |
| 04/17/2003 | US20030073621 Antidiabetic agents; isolated nucleic acid; genetic engineering |
| 04/17/2003 | US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy |
| 04/17/2003 | US20030073579 Plant growth regulator |
| 04/17/2003 | US20030073251 Plate-through hard mask for MRAM devices |
| 04/17/2003 | US20030073234 Preparation of clonal embryonic stem cell; prepare nutrient broth, inoculate with cells, propagate, monitor phenotype of cells, maintain culture of preferential cells |
| 04/17/2003 | US20030073233 Isolation of embryonic stem cells from animal embryos in vitro; prepare nutrient broth, inoculate with cell culture, propagate cells recover preferential stem cells |
| 04/17/2003 | US20030073223 For use in vaccines |
| 04/17/2003 | US20030073222 Multiply-substituted protease variants |
| 04/17/2003 | US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors |
| 04/17/2003 | US20030073216 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073215 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073214 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073213 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073212 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073211 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073210 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073208 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 04/17/2003 | US20030073196 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073194 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073193 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073192 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073191 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073189 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073187 Nucleotide sequences coding polypeptide for use in treatment and prevention of infection, induction of shock and inflammatory disease |
| 04/17/2003 | US20030073186 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073185 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073184 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073183 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073182 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073181 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073180 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073178 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073177 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073176 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073175 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073168 Polypeptide for use in the diagnosis, treatment and prevention of cardiovascular diseases |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030073165 Directed evolution of thermophilic enzymes |
| 04/17/2003 | US20030073161 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and immunological disorders |
| 04/17/2003 | US20030073159 Nucleotide sequences coding polypeptide for use in the treatment of tumors and viral diseases |
| 04/17/2003 | US20030073157 Synthetic peptides, conjugation reagents and methods |
| 04/17/2003 | US20030073141 Monoclonal antibodies against a complex of human ACT and a serine protease |
| 04/17/2003 | US20030073137 Periostin-based diagnostic assays |
| 04/17/2003 | US20030073131 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073130 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073129 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073095 Nucleotide sequences coding bacterial protein for use in the treatment and prevention of bacterial infections |
| 04/17/2003 | US20030073092 Modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments |
| 04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
| 04/17/2003 | US20030073079 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |
| 04/17/2003 | US20030073077 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |
| 04/17/2003 | US20030073072 Chimeric adenoviruses |
| 04/17/2003 | US20030072938 Trans-lentiviral vector particles and transduction of eukaryotic cells therewith |
| 04/17/2003 | US20030072826 Pine cone extracts and uses thereof |
| 04/17/2003 | US20030072812 Administering at a tumor site in a mammalian subject a pharmaceutically acceptable form of at least one iron compound or complex in a suitable carrier for therapy of breast cancer |
| 04/17/2003 | US20030072796 For activating T lymphocytes in vitro for the treatment of disease conditions |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072766 Comprising antiserum raised against a flagellaless Campylobacter strain for prophylaxis of Campylobacter colonisation in animals |
| 04/17/2003 | US20030072765 For therapy and prophylaxis of bacterial infections |
| 04/17/2003 | US20030072760 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 04/17/2003 | US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/17/2003 | US20030072751 Idiotypic vaccination against b cell lymphoma |
| 04/17/2003 | US20030072749 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
| 04/17/2003 | US20030072745 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030072743 Genetically modifying phagocyte to express an apoptotic cell receptor with enhanced ability to capture apoptotic cells; or increase expression of an apoptotic-cell receptor |
| 04/17/2003 | US20030072741 Medical devices for uses in repair of damaged tissues and therapeutic agent determinations |
| 04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
| 04/17/2003 | US20030071835 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030071834 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | DE10139783C1 Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung Cell compositions for the treatment of osteoarthritis, as well as processes for their preparation |
| 04/17/2003 | CA2463553A1 Gastrointestinal chemosensory receptors |
| 04/17/2003 | CA2463453A1 Methods of preparing a targeting vector and uses thereof |
| 04/17/2003 | CA2463442A1 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
| 04/17/2003 | CA2462914A1 Methods, compositions, and automated systems for separating rare cells from fluid samples |
| 04/17/2003 | CA2462873A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | CA2461900A1 Leukocyte inactivation module |
| 04/17/2003 | CA2461824A1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | CA2461655A1 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
| 04/17/2003 | CA2461429A1 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | CA2461343A1 Mammalian c-type lectins |
| 04/17/2003 | CA2461315A1 Toll-like receptor 3 signaling agonists and antagonists |
| 04/17/2003 | CA2460625A1 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
| 04/16/2003 | EP1302544A1 Medium additives and media for culturing animal cells |
| 04/16/2003 | EP1302541A1 Receptor protein specifically recognizing bacterial dna |
| 04/16/2003 | EP1302536A2 Embryonic stem cells and neural progenitor cells derived therefrom |
| 04/16/2003 | EP1302535A1 Heart muscle-like cell sheet, three-dimensional construct, heart muscle-like tissue and process for producing the same |
| 04/16/2003 | EP1302534A1 Cell fraction containing cells capable of differentiating into neural cells |